India, April 30 -- Shares of Nutriband Inc. (NTRB) jumped over 21% on Wednesday morning after CEO Gareth Sheridan released a shareholder letter highlighting the company's achievements in 2024 and outlook for 2025.
NTRB is currently trading at $6.89, up $1.21 or 21.30%, on the Nasdaq. The stock opened its trading at $7.10 after closing Tuesday at $5.68. The stock has traded between $3.30 and $11.78 in the past 52-week period.
The company is developing AVERSA technology, aimed at creating the world's first abuse-deterrent transdermal drug delivery system.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
In partnership with Kindeva Drug Delivery, Nutriband is developing AVERSA Fentanyl, projected to reac...